AI

How a small accelerator born at the Francis Crick Institute is helping UK start-ups find investors who speak their language

A wearable sensor and machine learning are giving epilepsy patients weeks of seizure monitoring where days used to be the limit.

Bioconvergence products blur the lines between drugs, devices and software – and with them, the rules for getting to market.

The burgeoning space that mixes biology, engineering, computer science and AI has already delivered some big exits.

The reach of artificial intelligence now spans the entire drug pipeline, prompting Big Pharma to reconsider outsourcing innovation.

Fund II, which closed on $35m, attracted commitments from Reinsurance Group of America, MassMutual, Bank of America and the Stellar Development Foundation.

The Canadian VC's sophomore fund, which is targeting $125m, held a first close on $58m, with support from Ceniarth, Equality Fund, KfW, Skoll Foundation and Wire Group.

The firm's eighth flagship has raised $350m to invest in companies developing 'picks and shovels' for AI.

Public markets are signaling they’re skeptical about AI valuations. Should Anthropic backers be worried?

With commitments from returning LPs, as well as new endowments, family offices and its first two public pension plans, the new fund has made 12 investments to date.